Carbidopa (KAISER FOUNDATION HOSPITALS)
Welcome to the PulseAid listing for the Carbidopa drug offered from KAISER FOUNDATION HOSPITALS. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | KAISER FOUNDATION HOSPITALS |
| NON-PROPRIETARY NAME: | Carbidopa Tablets |
| SUBSTANCE NAME: | CARBIDOPA |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
| START MARKETING DATE: | 2017-02-14 |
| END MARKETING DATE: | 0000-00-00 |
Carbidopa HUMAN PRESCRIPTION DRUG Details:
| Item Description | Carbidopa from KAISER FOUNDATION HOSPITALS |
| LABELER NAME: | KAISER FOUNDATION HOSPITALS |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 25(mg/1) |
| START MARKETING DATE: | 2017-02-14 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0179-0226_da976778-fca5-43c4-b890-c5aa75d906d9 |
| PRODUCT NDC: | 0179-0226 |
| APPLICATION NUMBER: | NDA017830 |
Other CARBIDOPA Pharmaceutical Manufacturers / Labelers:
